nodes	percent_of_prediction	percent_of_DWPC	metapath
Azilsartan medoxomil—AGTR1—Arf6 trafficking events—BIN1—Alzheimer's disease	0.0445	0.146	CbGpPWpGaD
Azilsartan medoxomil—Blood creatine phosphokinase increased—Donepezil—Alzheimer's disease	0.0396	0.0594	CcSEcCtD
Azilsartan medoxomil—Blood creatine phosphokinase increased—Rivastigmine—Alzheimer's disease	0.0352	0.0527	CcSEcCtD
Azilsartan medoxomil—Hyperuricaemia—Memantine—Alzheimer's disease	0.0267	0.04	CcSEcCtD
Azilsartan medoxomil—Blood uric acid increased—Memantine—Alzheimer's disease	0.0252	0.0378	CcSEcCtD
Azilsartan medoxomil—AGTR1—ACE Inhibitor Pathway—ACE—Alzheimer's disease	0.0207	0.068	CbGpPWpGaD
Azilsartan medoxomil—Blood creatinine increased—Donepezil—Alzheimer's disease	0.0185	0.0278	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Galantamine—Alzheimer's disease	0.0174	0.0261	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Galantamine—Alzheimer's disease	0.0174	0.026	CcSEcCtD
Azilsartan medoxomil—Blood creatinine increased—Memantine—Alzheimer's disease	0.0168	0.0252	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Galantamine—Alzheimer's disease	0.016	0.024	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Galantamine—Alzheimer's disease	0.0148	0.0222	CcSEcCtD
Azilsartan medoxomil—Telmisartan—PPARG—Alzheimer's disease	0.0138	0.483	CrCbGaD
Azilsartan medoxomil—Oedema peripheral—Donepezil—Alzheimer's disease	0.0135	0.0202	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.013	0.0195	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—LRRK2—Alzheimer's disease	0.0128	0.042	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Galantamine—Alzheimer's disease	0.0123	0.0184	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Memantine—Alzheimer's disease	0.0122	0.0184	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Memantine—Alzheimer's disease	0.0122	0.0183	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Galantamine—Alzheimer's disease	0.0122	0.0183	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.012	0.018	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.0119	0.0179	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Donepezil—Alzheimer's disease	0.0115	0.0172	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Memantine—Alzheimer's disease	0.0113	0.0169	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Rivastigmine—Alzheimer's disease	0.011	0.0165	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.0108	0.0162	CcSEcCtD
Azilsartan medoxomil—Fatigue—Galantamine—Alzheimer's disease	0.0108	0.0162	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Rivastigmine—Alzheimer's disease	0.0102	0.0153	CcSEcCtD
Azilsartan medoxomil—AGTR1—ACE Inhibitor Pathway—NOS3—Alzheimer's disease	0.00962	0.0316	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Donepezil—Alzheimer's disease	0.00954	0.0143	CcSEcCtD
Azilsartan medoxomil—Asthenia—Galantamine—Alzheimer's disease	0.009	0.0135	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00895	0.0134	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Memantine—Alzheimer's disease	0.00866	0.013	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Galantamine—Alzheimer's disease	0.00859	0.0129	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Memantine—Alzheimer's disease	0.00858	0.0129	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00847	0.0127	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.0084	0.0126	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Rivastigmine—Alzheimer's disease	0.00839	0.0126	CcSEcCtD
Azilsartan medoxomil—Fatigue—Donepezil—Alzheimer's disease	0.00839	0.0126	CcSEcCtD
Azilsartan medoxomil—Dizziness—Galantamine—Alzheimer's disease	0.0083	0.0124	CcSEcCtD
Azilsartan medoxomil—Candesartan—PTGS1—Alzheimer's disease	0.00824	0.287	CrCbGaD
Azilsartan medoxomil—Rash—Galantamine—Alzheimer's disease	0.00791	0.0119	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Galantamine—Alzheimer's disease	0.00791	0.0119	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00762	0.0114	CcSEcCtD
Azilsartan medoxomil—Fatigue—Memantine—Alzheimer's disease	0.00761	0.0114	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00746	0.0112	CcSEcCtD
Azilsartan medoxomil—Nausea—Galantamine—Alzheimer's disease	0.00745	0.0112	CcSEcCtD
Azilsartan medoxomil—Fatigue—Rivastigmine—Alzheimer's disease	0.00745	0.0112	CcSEcCtD
Azilsartan medoxomil—Asthenia—Donepezil—Alzheimer's disease	0.00698	0.0105	CcSEcCtD
Azilsartan medoxomil—Pruritus—Donepezil—Alzheimer's disease	0.00688	0.0103	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—PYY—Alzheimer's disease	0.00669	0.022	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Donepezil—Alzheimer's disease	0.00665	0.00998	CcSEcCtD
Azilsartan medoxomil—Losartan—ACE—Alzheimer's disease	0.0066	0.23	CrCbGaD
Azilsartan medoxomil—Dizziness—Donepezil—Alzheimer's disease	0.00643	0.00964	CcSEcCtD
Azilsartan medoxomil—AGTR1—ACE Inhibitor Pathway—TGFB1—Alzheimer's disease	0.00636	0.0209	CbGpPWpGaD
Azilsartan medoxomil—Asthenia—Memantine—Alzheimer's disease	0.00634	0.0095	CcSEcCtD
Azilsartan medoxomil—Pruritus—Memantine—Alzheimer's disease	0.00625	0.00937	CcSEcCtD
Azilsartan medoxomil—Asthenia—Rivastigmine—Alzheimer's disease	0.0062	0.00929	CcSEcCtD
Azilsartan medoxomil—Rash—Donepezil—Alzheimer's disease	0.00613	0.00919	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Donepezil—Alzheimer's disease	0.00613	0.00918	CcSEcCtD
Azilsartan medoxomil—Pruritus—Rivastigmine—Alzheimer's disease	0.00611	0.00916	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Memantine—Alzheimer's disease	0.00604	0.00906	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00591	0.00886	CcSEcCtD
Azilsartan medoxomil—Dizziness—Memantine—Alzheimer's disease	0.00584	0.00875	CcSEcCtD
Azilsartan medoxomil—Nausea—Donepezil—Alzheimer's disease	0.00578	0.00866	CcSEcCtD
Azilsartan medoxomil—Dizziness—Rivastigmine—Alzheimer's disease	0.00571	0.00856	CcSEcCtD
Azilsartan medoxomil—Rash—Memantine—Alzheimer's disease	0.00557	0.00835	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Memantine—Alzheimer's disease	0.00556	0.00834	CcSEcCtD
Azilsartan medoxomil—Rash—Rivastigmine—Alzheimer's disease	0.00545	0.00817	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Rivastigmine—Alzheimer's disease	0.00544	0.00816	CcSEcCtD
Azilsartan medoxomil—Nausea—Memantine—Alzheimer's disease	0.00525	0.00786	CcSEcCtD
Azilsartan medoxomil—Nausea—Rivastigmine—Alzheimer's disease	0.00513	0.00769	CcSEcCtD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—F2—Alzheimer's disease	0.00511	0.0168	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Arf6 trafficking events—INS—Alzheimer's disease	0.00486	0.016	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—GAL—Alzheimer's disease	0.00463	0.0152	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL1A—Alzheimer's disease	0.00459	0.0151	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—PYY—Alzheimer's disease	0.00449	0.0147	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—HTR6—Alzheimer's disease	0.00437	0.0144	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide GPCRs—CCR5—Alzheimer's disease	0.00435	0.0143	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—Alzheimer's disease	0.00406	0.0133	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR6—Alzheimer's disease	0.00374	0.0123	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—NPY—Alzheimer's disease	0.00364	0.012	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—PYY—Alzheimer's disease	0.00342	0.0112	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—NPS—Alzheimer's disease	0.00337	0.0111	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—NPS—Alzheimer's disease	0.00333	0.0109	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—SST—Alzheimer's disease	0.00318	0.0104	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK8—Alzheimer's disease	0.00317	0.0104	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—APP—Alzheimer's disease	0.00314	0.0103	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	0.00311	0.0102	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—APP—Alzheimer's disease	0.0031	0.0102	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—Alzheimer's disease	0.00302	0.00991	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—PLCB1—Alzheimer's disease	0.00296	0.00972	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—HTR6—Alzheimer's disease	0.00285	0.00937	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—APP—Alzheimer's disease	0.0028	0.00922	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PLCB1—Alzheimer's disease	0.00265	0.0087	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—Alzheimer's disease	0.00251	0.00824	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.00244	0.00803	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL1B—Alzheimer's disease	0.0024	0.00787	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—CASP3—Alzheimer's disease	0.00239	0.00786	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—GAL—Alzheimer's disease	0.00237	0.00778	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.00223	0.00734	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.00213	0.007	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.00208	0.00683	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCR5—Alzheimer's disease	0.00205	0.00673	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—HTR2A—Alzheimer's disease	0.00203	0.00667	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—VEGFA—Alzheimer's disease	0.00203	0.00667	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PYY—Alzheimer's disease	0.00193	0.00634	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—Alzheimer's disease	0.00187	0.00613	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—TGFB1—Alzheimer's disease	0.00186	0.00612	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—NPY—Alzheimer's disease	0.00186	0.00611	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—IAPP—Alzheimer's disease	0.00185	0.00607	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Alzheimer's disease	0.00181	0.00596	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CRH—Alzheimer's disease	0.00179	0.0059	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—F2—Alzheimer's disease	0.00178	0.00585	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—F2—Alzheimer's disease	0.00176	0.00577	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PYY—Alzheimer's disease	0.00175	0.00576	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—TNF—Alzheimer's disease	0.00174	0.00571	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—NPS—Alzheimer's disease	0.0017	0.00559	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—SST—Alzheimer's disease	0.00162	0.00533	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HTR6—Alzheimer's disease	0.00161	0.0053	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.0016	0.00527	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—Alzheimer's disease	0.00159	0.00523	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—APP—Alzheimer's disease	0.00158	0.0052	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.00157	0.00516	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCL2—Alzheimer's disease	0.00157	0.00515	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CDK5—Alzheimer's disease	0.00152	0.005	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HTR6—Alzheimer's disease	0.00146	0.00481	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—Alzheimer's disease	0.00145	0.00476	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.00137	0.00451	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.00134	0.00442	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GAL—Alzheimer's disease	0.00134	0.0044	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GAL—Alzheimer's disease	0.00121	0.00399	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TTR—Alzheimer's disease	0.00118	0.00389	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.00118	0.00387	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—NPY—Alzheimer's disease	0.00105	0.00345	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.00105	0.00345	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCR5—Alzheimer's disease	0.00105	0.00344	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—IAPP—Alzheimer's disease	0.00104	0.00343	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PYY—Alzheimer's disease	0.00104	0.0034	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—HTR2A—Alzheimer's disease	0.00102	0.00336	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CRH—Alzheimer's disease	0.00101	0.00333	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—NPS—Alzheimer's disease	0.000961	0.00316	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—NPY—Alzheimer's disease	0.000954	0.00314	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IAPP—Alzheimer's disease	0.000948	0.00312	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CRH—Alzheimer's disease	0.000921	0.00303	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000917	0.00301	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—SST—Alzheimer's disease	0.000917	0.00301	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CDK5—Alzheimer's disease	0.000898	0.00295	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—F2—Alzheimer's disease	0.000897	0.00295	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—APP—Alzheimer's disease	0.000894	0.00294	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—NPS—Alzheimer's disease	0.000873	0.00287	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000869	0.00285	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HTR6—Alzheimer's disease	0.000864	0.00284	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000843	0.00277	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GAB2—Alzheimer's disease	0.000833	0.00274	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—SST—Alzheimer's disease	0.000833	0.00274	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—APP—Alzheimer's disease	0.000811	0.00267	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL2—Alzheimer's disease	0.0008	0.00263	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PSENEN—Alzheimer's disease	0.000785	0.00258	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—APH1A—Alzheimer's disease	0.000774	0.00254	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000766	0.00252	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NCSTN—Alzheimer's disease	0.000753	0.00248	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—LRP1—Alzheimer's disease	0.000735	0.00242	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GAL—Alzheimer's disease	0.000718	0.00236	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GFAP—Alzheimer's disease	0.000718	0.00236	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—A2M—Alzheimer's disease	0.000633	0.00208	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	0.00063	0.00207	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000624	0.00205	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PSEN2—Alzheimer's disease	0.000613	0.00201	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000591	0.00194	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000578	0.0019	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000566	0.00186	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NPY—Alzheimer's disease	0.000564	0.00185	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IAPP—Alzheimer's disease	0.00056	0.00184	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CRH—Alzheimer's disease	0.000544	0.00179	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCR5—Alzheimer's disease	0.000537	0.00176	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000525	0.00173	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NPS—Alzheimer's disease	0.000516	0.00169	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000513	0.00169	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—F2—Alzheimer's disease	0.000507	0.00167	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PTK2B—Alzheimer's disease	0.000506	0.00166	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SST—Alzheimer's disease	0.000492	0.00162	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NTRK2—Alzheimer's disease	0.000492	0.00162	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GAB2—Alzheimer's disease	0.000492	0.00162	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CALM1—Alzheimer's disease	0.00049	0.00161	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GSK3A—Alzheimer's disease	0.000488	0.0016	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—APP—Alzheimer's disease	0.000479	0.00158	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—F2—Alzheimer's disease	0.00046	0.00151	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PLCB1—Alzheimer's disease	0.000452	0.00149	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NGFR—Alzheimer's disease	0.000422	0.00139	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CREB1—Alzheimer's disease	0.000419	0.00138	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ADAM10—Alzheimer's disease	0.000412	0.00135	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL2—Alzheimer's disease	0.00041	0.00135	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—S100B—Alzheimer's disease	0.00039	0.00128	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IGF2—Alzheimer's disease	0.000371	0.00122	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IGF1R—Alzheimer's disease	0.000359	0.00118	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—LPL—Alzheimer's disease	0.000344	0.00113	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MEF2C—Alzheimer's disease	0.000341	0.00112	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PRKCG—Alzheimer's disease	0.000335	0.0011	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NGF—Alzheimer's disease	0.000326	0.00107	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCR5—Alzheimer's disease	0.000317	0.00104	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HTR2A—Alzheimer's disease	0.00031	0.00102	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CALM1—Alzheimer's disease	0.000289	0.000951	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—APOE—Alzheimer's disease	0.000288	0.000948	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—LEP—Alzheimer's disease	0.000288	0.000948	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CAV1—Alzheimer's disease	0.000286	0.000939	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ESR1—Alzheimer's disease	0.000275	0.000905	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—F2—Alzheimer's disease	0.000272	0.000894	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000266	0.000875	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GSK3B—Alzheimer's disease	0.00025	0.000821	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CREB1—Alzheimer's disease	0.000248	0.000814	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—INS—Alzheimer's disease	0.000246	0.00081	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL2—Alzheimer's disease	0.000242	0.000797	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IGF1—Alzheimer's disease	0.000238	0.000783	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NOS3—Alzheimer's disease	0.000216	0.00071	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—AKT1—Alzheimer's disease	0.000185	0.000609	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CASP3—Alzheimer's disease	0.000183	0.000603	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL6—Alzheimer's disease	0.000182	0.000599	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MAPK8—Alzheimer's disease	0.000169	0.000554	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—AKT1—Alzheimer's disease	0.000168	0.000553	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—VEGFA—Alzheimer's disease	0.000156	0.000512	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TGFB1—Alzheimer's disease	0.000143	0.00047	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TP53—Alzheimer's disease	0.000118	0.000387	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL6—Alzheimer's disease	0.000108	0.000354	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—AKT1—Alzheimer's disease	9.93e-05	0.000326	CbGpPWpGaD
